Bilaketaren emaitzak - R Abrahams

  • Erakusten 1 - 8 emaitzak -- 8
Findu emaitzak
  1. 1
    Efficacy and safety of combining olodaterol Respimat® and tiotropium HandiHaler® in patients with COPD: results of two randomized, double-blind, active-controlled studies

    Efficacy and safety of combining olodaterol Respimat® and tiotropium HandiHaler® in patients with COPD: results of two randomized, double-blind, active-controlled s... nork Richard ZuWallack, Lisa Allen, Gemzel Hernandez, Naitee Ting, R Abrahams

    Argitaratua 2014
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Efficacy of Tiotropium + Olodaterol in Patients with Chronic Obstructive Pulmonary Disease by Initial Disease Severity and Treatment Intensity: A Post Hoc Analysis

    Efficacy of Tiotropium + Olodaterol in Patients with Chronic Obstructive Pulmonary Disease by Initial Disease Severity and Treatment Intensity: A Post Hoc Analysis nork Gary T. Ferguson, Matjaž Fležar, Stephanie Korn, Lawrence Korducki, Lars Grönke, R Abrahams, Roland Buhl

    Argitaratua 2015
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Tiotropium + olodaterol shows clinically meaningful improvements in quality of life

    Tiotropium + olodaterol shows clinically meaningful improvements in quality of life nork Dave Singh, Gary T. Ferguson, J Bolitschek, Lars Grönke, Christoph Hallmann, Nathan Bennett, R Abrahams, Olaf Schmidt, Leif Bjermer

    Argitaratua 2015
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Thrombin promotes diet-induced obesity through fibrin-driven inflammation

    Thrombin promotes diet-induced obesity through fibrin-driven inflammation nork Anna K. Kopec, Sara R. Abrahams, Sherry Thornton, Joseph S. Palumbo, Eric S. Mullins, Senad Divanovic, Hartmut Weiler, A. Phillip Owens, Nigel Mackman, Ashley Goss, Joanne van Ryn, James P. Luyendyk, Matthew J. Flick

    Argitaratua 2017
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Tiotropium and olodaterol fixed-dose combination<i>versus</i>mono-components in COPD (GOLD 2–4)

    Tiotropium and olodaterol fixed-dose combination<i>versus</i>mono-components in COPD (GOLD 2–4) nork Roland Buhl, François Maltais, R Abrahams, Leif Bjermer, Eric Derom, Gary T. Ferguson, Matjaž Fležar, Jacques Hébert, Lorcan McGarvey, Emílio Pizzichini, Jim Reid, Antony Veale, Lars Grönke, Alan Hamilton, Lawrence Korducki, Kay Tetzlaff, Stella Waitere-Wijker, Henrik Watz, Eric Bateman

    Argitaratua 2015
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Targeting mitochondrial translation by inhibiting DDX3: a novel radiosensitization strategy for cancer treatment

    Targeting mitochondrial translation by inhibiting DDX3: a novel radiosensitization strategy for cancer treatment nork Marise R. Heerma van Voss, Farhad Vesuna, Guus M. Bol, Junaid Afzal, Saritha Tantravedi, Yehudit Bergman, Kai Kammers, Mohamed Lehar, Reem Malek, Matthew Ballew, Natalie D. ter Hoeve, Diane S. Abou, Daniel L.J. Thorek, Cynthia Berlinicke, Meysam Yazdankhah, Debasish Sinha, Anne Le, R. Abrahams, Phuoc T. Tran, P. J. van Diest, Venu Raman

    Argitaratua 2017
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Lipid nanoparticles and siRNA targeting plasminogen provide lasting inhibition of fibrinolysis in mouse and dog models of hemophilia A

    Lipid nanoparticles and siRNA targeting plasminogen provide lasting inhibition of fibrinolysis in mouse and dog models of hemophilia A nork Amy W. Strilchuk, Woosuk S. Hur, Paul Batty, Yaqiu Sang, Sara R. Abrahams, Alyssa S. M. Yong, Jerry Leung, Lakmali M. Silva, Jocelyn A. Schroeder, Kate Nesbitt, Bas de Laat, Niki M. Moutsopoulos, Thomas Bugge, Qizhen Shi, Pieter R. Cullis, Elizabeth P. Merricks, Alisa S. Wolberg, Matthew J. Flick, David Lillicrap, Timothy C. Nichols, Christian J. Kastrup

    Argitaratua 2024
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial

    CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial nork Aili L. Lazaar, Bruce E. Miller, Alison Donald, Thomas Keeley, Claire Ambery, John J. Russell, Henrik Watz, Ruth Tal‐Singer, Philip G. Bardin, Peter Bremner, David Langton, Anne-Marie Southcott, Paul S. Thomas, John R. Wheatley, Kenneth R. Chapman, Murdo Ferguson, L. Homik, François Maltais, Bonavuth Pek, Eric St-Amour, Tamara Eckermann, A. Eich, Guido Ern, Karin Foerster, A. Förster, Martin Hoffmann, Claus Keller, Anneliese Linnhoff, Ruth Nischik, Isabelle Schenkenberger, Olaf Schmidt, Joong Hyun Ahn, Hee Soon Chung, Do-Jin Kim, Jae Yeol Kim, Sang Haak Lee, Yeon‐Mok Oh, Myung Jae Park, Suk Joong Yong, Simone Van der Sar, Pascal Wielders, Anna Olech-Cudzik, Krzysztof Wytrychowski, Ghiulten Apti, Andreia Madalina Balta, Doru Didita, Livia Filip, Bogdan Mihai Mincu, Viorica Mincu, Roxana Maria Nemeş, Maria Elena Scridon, Antigona Trofor, Dragos G. Ungurean, R. Agüero Balbín, Miguel Barrueco Ferrero, José Maria Echave-Sustaeta, José M. Marı́n, Eduardo Monso Mola, Sergi Pascual-Guàrdia, Germán Peces-Barba Romero, R Abrahams, Thomas M. Hyers, Edward Kerwin, Shawn M. Magee, Murali Ramaswamy, James M. Wells

    Argitaratua 2020
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: